NCT05206305View on ClinicalTrials.gov

Sensory-Evoked Cortical Gamma Oscillation

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Alzheimer Disease
Interventions
DEVICE

GammaSense Stimulation device

Cognito Therapeutics GammaSense Stimulation device delivers sensory (auditory and visual) stimuli at a rate of 40 Hz to the wearer for one hour each day.

Trial Locations (1)

37920

RECRUITING

University of Tennessee Medical Center, Knoxville

All Listed Sponsors
lead

University of Tennessee Medical Center

OTHER